Search Videos and More
Document
Variation in Prenatal Surveillance and Management of Anti-SSA/Ro Autoantibody Positive Pregnancies
Dr. Melanie Gropler co-authored this original article published in the Journal of Maternal-Fetal and Neonatal Medicine.
News
Phoenix Children's Research Institute Study Identifies FOXF1 Enhancers Involved in Rare Lung Disease
The FOXF1 protein is critically important in pulmonary vascular development, specifically responsible for the extension and branching of airways and blood vessels in the developing lung.
Video
Cardiac Evaluation and Potential for Prenatal through Postnatal Therapy
Dr. Lindblade led a discussion related to high risk fetal conditions (eg, sacrococcygeal teratoma, vein of Galen malformation, placental chorioangioma, etc.) and their cardiovascular implications.
News
Phoenix Children’s Opens 44,000-Square Foot Neonatal Intensive Care Unit
Children’s opened its new 44,000-square-foot Level IV neonatal intensive care unit (NICU) at the Phoenix Children’s Hospital – Thomas Campus on Wednesday, May 15.
News
Researchers at Phoenix Children’s First in the World to Produce Mouse Lungs in Rats
Research conducted at the Phoenix Children’s Research Institute at the University of Arizona College of Medicine - Phoenix reports the successful generation of a mouse lung in a rat, according to a paper published in the American Journal of Respiratory and Critical Care Medicine.
News
Phoenix Children’s Researcher Awarded $3 Million Grant to Develop New Therapy for Lung Diseases in Premature Babies
An internationally renowned research scientist at the Phoenix Children’s Research Institute at the University of Arizona College of Medicine – Phoenix has been awarded a multimillion-dollar grant from the National Institutes of Health (NIH) to develop new treatment methods for lung disease in premature infants.
News
Risk Factors For 1-Year Allograft Loss in Pediatric Heart Transplant Patients Using Machine Learning: An Analysis of the Pediatric Heart Transplant Society Database
Pediatric heart transplant patients are at greatest risk of allograft loss in the first year. We assessed whether machine learning could improve 1-year risk assessment using the Pediatric Heart Transplant Society database.
Symposium
2023 Perspectives in Bronchopulmonary Dysplasia – Pharmacology of BPD
In September 2023, Phoenix Children’s Center for Fetal and Neonatal Care hosted its annual Bronchopulmonary Dysplasia (BPD) Conference.
Video
Neuro-Sedative Use in the Inpatient Setting
Pharmacist Rhonda Kurz spoke on the variability in use of medications for BPD and variability of individual responses to medications.
Video
Patient and Family Perspective of Care – Assessing the Impact of Our Care
Dr. Deborah Tom moderated a panel discussion among parents of infants with BPD to explore how providers can better assess the needs of individual families and work within care teams to improve care delivery.
Video
Emerging Therapies for Prevention and Treatment of BPD
Dr. Vlad Kalinichenko considered the use of novel pharmacologic treatments that may prevent BPD and/or more effectively treat the manifestations of BPD.
Video
Systemic Corticosteroids – Timing is Everything
Dr. Amy Brown presented on how the timing of use of systemic corticosteroids may prevent BPD and/or more effectively treat the manifestations of BPD.